Dose‐dependent mesothelioma induction by intraperitoneal administration of multi‐wall carbon nanotubes in p53 heterozygous mice

Abstract

Among various types of multi‐wall carbon nanotubes ( MWCNT ) are those containing fibrous particles longer than 5 μm with an aspect ratio of more than three (i.e. dimensions similar to mesotheliomagenic asbestos). A previous study showed that micrometer‐sized MWCNT (μm‐ MWCNT ) administered intraperitoneally at a dose of 3000 μg/mouse corresponding to 1 × 10 9 fibers per mouse induced mesotheliomas in p53 heterozygous mice. Here, we report a dose‐response study; three groups of p53 heterozygous mice ( n = 20) were given a single intraperitoneal injection of 300 μg/mouse of μm‐ MWCNT (corresponding to 1 × 10 8 fibers), 30 μg/mouse (1 × 10 7 ) or 3 μg/mouse (1 × 10 6 ), respectively, and observed for up to 1 year. The cumulative incidence of mesotheliomas was 19/20, 17/20 and 5/20, respectively. The severity of peritoneal adhesion and granuloma formation were dose‐dependent and minimal in the lowest dose group. However, the time of tumor onset was apparently independent of the dose. All mice in the lowest dose group that survived until the terminal kill had microscopic atypical mesothelial hyperplasia considered as a precursor lesion of mesothelioma. Right beneath was a mononuclear cell accumulation consisting of CD 45‐ or CD 3‐positive lymphocytes and CD 45/ CD 3‐negative F 4/80 faintly positive macrophages; some of the macrophages contained singular MWCNT in their cytoplasm. The lesions were devoid of epithelioid cell granuloma and fibrosis. These findings were in favor of the widely proposed mode of action of fiber carcinogenesis, that is, frustrated phagocytosis where the mesotheliomagenic microenvironment on the peritoneal surface is neither qualitatively altered by the density of the fibers per area nor by the formation of granulomas against agglomerates. ( Cancer Sci , doi: 10.1111/j.1349‐7006.2012.02318.x, 2012)

Shown for reading. Its publisher allows quoting it, not republishing it.

References 29

1. 1.

   Service RF. CHEMISTRY: nanotubes: the next asbestos? Science. 1998;281:941.

   Not in our library

2. 2.

   Takagi A, Hirose A, Nishimura T, et al. Induction of mesothelioma in p53+/− mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105-16.

   Not in our library10.2131/jts.33.105

3. 3.

   Stanton MF, Layard M, Tegeris A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981;67:965-75.

   Not in our library

4. 4.

   Pott F, Roller M, Kamino K, Bellmann B. Significance of durability of mineral fibers for their toxicity and carcinogenic potency in the abdominal cavity of rats in comparison with the low sensitivity of inhalation studies. Environ Health Perspect. 1994;102(Suppl 5):145-50.

   Not in our library10.1289/ehp.94102s5145

5. 5.

   Adachi S, Yoshida S, Kawamura K, et al. Inductions of oxidative DNA damage and mesothelioma by crocidolite, with special reference to the presence of iron inside and outside of asbestos fiber. Carcinogenesis. 1994;15:753-8.

   Not in our library10.1093/carcin/15.4.753

6. 6.

   Roller M, Pott F, Kamino K, Althoff GH, Bellmann B. Dose-response relationship of fibrous dusts in intraperitoneal studies. Environ Health Perspect. 1997;105(Suppl 5):1253-6.

   Not in our library10.1289/ehp.97105s51253

7. 7.

   WHO Workshop on Mechanisms of Fibre Carcinogenesis and Assessment of Chrysotile Asbestos Substitutes. 2006.

   Not in our library

8. 8.

   Bernstein DM, Riego Sintes JM. Carcinogenicity of synthetic mineral fibres after intraperitoneal injection in rats (ECB/TM/18(97) rev. 1). Methods for the Determination of the Hazardous Properties for Human Health of Man Made Mineral Fibres (MMMF) (EUR 18748 EN [1999]). 1999;41-52.

   Not in our library

9. 9.

   Marsella JM, Liu BL, Vaslet CA, Kane AB. Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers. Environ Health Perspect. 1997;105(Suppl 5):1069-72.

   Not in our library10.1289/ehp.97105s51069

10. 10.

    Mahler JF, Flagler ND, Malarkey DE, Mann PC, Haseman JK, Eastin W. Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice. Toxicol Pathol. 1998;26:501-11.

    Not in our library10.1177/019262339802600406

11. 11.

    Eastin WC, Haseman JK, Mahler JF, Bucher JR. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol Pathol. 1998;26:461-73.

    Not in our library10.1177/019262339802600401

12. 12.

    Tsukada T, Tomooka Y, Takai S, et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 1993;8:3313-22.

    Not in our library

13. 13.

    Chung A, Cagle PT, Roggli VL. Tumors of the Serosal Membranes. 2006.

    Not in our library

14. 14.

    Chalabreysse L, Guillaud C, Tabib A, Loire R, Thivolet-Bejui F. Malignant mesothelioma with osteoblastic heterologous elements. Ann Pathol. 2001;21:428-30.

    Not in our library

15. 15.

    Matsukuma S, Aida S, Hata Y, Sugiura Y, Tamai S. Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Int. 1996;46:389-91.

    Not in our library10.1111/j.1440-1827.1996.tb03627.x

16. 16.

    Ordonez NG. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases. Mod Pathol. 2006;19:373-83.

    Not in our library10.1038/modpathol.3800543

17. 17.

    Courtice FC, Simmonds WJ. The removal of protein from the subarachnoid space. Aust J Exp Biol Med Sci. 1951;29:255-63.

    Not in our library10.1038/icb.1951.30

18. 18.

    Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009;117:1-14.

    Not in our library10.1007/s00401-008-0457-0

19. 19.

    1986.

    Not in our library

20. 20.

    1990.

    Not in our library

21. 21.

    Boffetta P, Burdorf A, Goldberg M, Merler E, Siemiatycki J. Towards the coordination of European research on the carcinogenic effects of asbestos. Scand J Work Environ Health. 1998;24:312-7.

    Not in our library

22. 22.

    Yano E, Wang ZM, Wang XR, Wang MZ, Lan YJ. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. Am J Epidemiol. 2001;154:538-43.

    Not in our library10.1093/aje/154.6.538

23. 23.
    Asbestos, carbon nanotubes and the pleural mesothelium: a review and the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma · 2010

    No notice
24. 24.

    Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-8.

    Not in our library10.1038/nnano.2008.111

25. 25.

    Nagai H, Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys. 2010;502:1-7.

    Not in our library10.1016/j.abb.2010.06.015

26. 26.

    Tossavainen A, Karjalainen A, Karhunen PJ. Retention of asbestos fibers in the human body. Environ Health Perspect. 1994;102(Suppl 5):253-5.

    Not in our library10.1289/ehp.94102s5253

27. 27.

    Miserocchi G, Sancini G, Mantegazza F, Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ Health. 2008;7:4.

    Not in our library10.1186/1476-069x-7-4

28. 28.

    Goldsmith JR. Asbestos as a systemic carcinogen: the evidence from eleven cohorts. Am J Ind Med. 1982;3:341-8.

    Not in our library10.1002/ajim.4700030309

29. 29.

    Noonan CW, Pfau JC, Larson TC, Spence MR. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect. 2006;114:1243-7.

    Not in our library10.1289/ehp.9203

Cited by papers we hold 5

• In vivo genotoxicity assessment of a multiwalled carbon nanotube in a mouse ex vivo culture · 2022
  Not checked
• Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats · 2015
  No notice
• The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats · 2014
  No notice
• Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes · 2014
  No notice
• Transcriptomic analysis reveals novel mechanistic insight into murine biological responses to multi-walled carbon nanotubes in lungs and cultured lung epithelial cells. · 2013
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.